1. Home
  2. VCTR vs TMDX Comparison

VCTR vs TMDX Comparison

Compare VCTR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCTR
  • TMDX
  • Stock Information
  • Founded
  • VCTR 2013
  • TMDX 1998
  • Country
  • VCTR United States
  • TMDX United States
  • Employees
  • VCTR N/A
  • TMDX N/A
  • Industry
  • VCTR Investment Managers
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VCTR Finance
  • TMDX Health Care
  • Exchange
  • VCTR Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • VCTR 4.4B
  • TMDX 4.8B
  • IPO Year
  • VCTR 2018
  • TMDX 2019
  • Fundamental
  • Price
  • VCTR $64.57
  • TMDX $129.15
  • Analyst Decision
  • VCTR Buy
  • TMDX Buy
  • Analyst Count
  • VCTR 10
  • TMDX 10
  • Target Price
  • VCTR $70.80
  • TMDX $127.33
  • AVG Volume (30 Days)
  • VCTR 379.0K
  • TMDX 808.7K
  • Earning Date
  • VCTR 08-07-2025
  • TMDX 07-30-2025
  • Dividend Yield
  • VCTR 3.01%
  • TMDX N/A
  • EPS Growth
  • VCTR 38.50
  • TMDX N/A
  • EPS
  • VCTR 4.50
  • TMDX 1.41
  • Revenue
  • VCTR $897,222,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • VCTR $42.70
  • TMDX $34.07
  • Revenue Next Year
  • VCTR $15.14
  • TMDX $20.76
  • P/E Ratio
  • VCTR $14.44
  • TMDX $91.70
  • Revenue Growth
  • VCTR 7.38
  • TMDX 64.43
  • 52 Week Low
  • VCTR $43.82
  • TMDX $55.00
  • 52 Week High
  • VCTR $73.42
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • VCTR 62.24
  • TMDX 51.09
  • Support Level
  • VCTR $62.42
  • TMDX $120.36
  • Resistance Level
  • VCTR $65.77
  • TMDX $136.63
  • Average True Range (ATR)
  • VCTR 1.62
  • TMDX 6.03
  • MACD
  • VCTR 0.19
  • TMDX -1.68
  • Stochastic Oscillator
  • VCTR 90.11
  • TMDX 35.12

About VCTR Victory Capital Holdings Inc.

Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: